C07D 207/10
With hetero atoms or with carbon atoms having three bonds to hetero
Official title: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
C07D207/10 (With hetero atoms or with carbon atoms having three bonds to hetero) appears on 3,395 US grants and 3,410 published applications in this corpus.
Search patents in C07D- Granted patents
- 3,395
- Published applications
- 3,410
- Assignees
- 1,373
- Inventors
- 9,608
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 21 | 0 |
| 1977 | 14 | 0 |
| 1978 | 29 | 0 |
| 1979 | 31 | 0 |
| 1980 | 27 | 0 |
| 1981 | 33 | 0 |
| 1982 | 34 | 0 |
| 1983 | 15 | 0 |
| 1984 | 23 | 0 |
| 1985 | 24 | 0 |
| 1986 | 26 | 0 |
| 1987 | 43 | 0 |
| 1988 | 31 | 0 |
| 1989 | 34 | 0 |
| 1990 | 35 | 0 |
| 1991 | 39 | 0 |
| 1992 | 32 | 0 |
| 1993 | 32 | 0 |
| 1994 | 32 | 0 |
| 1995 | 57 | 0 |
| 1996 | 54 | 0 |
| 1997 | 78 | 0 |
| 1998 | 68 | 0 |
| 1999 | 78 | 0 |
| 2000 | 76 | 0 |
| 2001 | 89 | 26 |
| 2002 | 102 | 124 |
| 2003 | 88 | 119 |
| 2004 | 73 | 190 |
| 2005 | 70 | 191 |
| 2006 | 95 | 131 |
| 2007 | 89 | 159 |
| 2008 | 89 | 137 |
| 2009 | 107 | 166 |
| 2010 | 114 | 155 |
| 2011 | 108 | 142 |
| 2012 | 109 | 124 |
| 2013 | 107 | 117 |
| 2014 | 115 | 134 |
| 2015 | 106 | 145 |
| 2016 | 97 | 125 |
| 2017 | 118 | 124 |
| 2018 | 76 | 110 |
| 2019 | 96 | 109 |
| 2020 | 101 | 149 |
| 2021 | 117 | 131 |
| 2022 | 81 | 105 |
| 2023 | 66 | 125 |
| 2024 | 65 | 129 |
| 2025 | 82 | 117 |
| 2026 | 69 | 126 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- P38alpha mitogen-activated protein kinase inhibitors6 Oct 2026US 12,753,184 B2Gen1E Lifesciences Inc.
- Bioactive phytochemicals in Zizyphus and guarana29 Sep 2026US 12,747,206 B2Phytoquest Limited
- TEAD inhibitors29 Sep 2026US 12,747,207 B2Orion Corporation
- Amino acid compositions22 Sep 2026US 12,741,941 B2ThermoLife International, LLC
- Inhibitors of spinster homolog 2 (SPNS2) for use in therapy22 Sep 2026US 12,741,944 B2University of Virginia Patent Foundation
- Amino acid-derived ceramide, synthesis method therefor and use thereof1 Oct 2026US 2026/0297018 A1Shenzhen Dikeman Biotechnology Co., Ltd.
- Glycopyrrolate salts24 Sep 2026US 2026/0284007 A1Journey Medical Corporation
- Crystalline complexes between velagliflozin and selected co-crystal forming agents, methods for their preparation and the use thereof for preparing medicaments24 Sep 2026US 2026/0285825 A1Boehringer Ingelheim Vetmedica GmbH
- Radiolabeled Fibroblast Activation Protein Inhibitors and Methods of Making Same17 Sep 2026US 2026/0273110 A1The Regents of the University of Michigan
- Trpv1 agonist and uses thereof17 Sep 2026US 2026/0274802 A1SciTherm Therapeutics Corporation
Most cited
By later US patents
- Pyrrolidine-containing monomers and oligomers675US 5,519,134 AIsis Pharmaceuticals, Inc. · 1996
- Trifunctional intermediates for preparing 3'-tailed oligonucleotides292US 5,512,667 A1996
- Proline derivatives and related compounds230US 4,105,776 AE. R. Squibb & Sons, Inc. · 1978
- Methods for synthesizing diverse collections of pyrrolidine compounds218US 5,525,735 AAffymax Technologies N.V. · 1996
- Arylsulfonylamino hydroxamic acid derivatives213US 5,863,949 APfizer Inc. · 1999